Theravance Biopharma Market Cap

Theravance Biopharma has a market cap or net worth of €807.81 million as of January 30, 2026. Its market cap has increased by 96.31% in one year.

Market Cap

807.81M

Enterprise Value

565.30M

Revenue

68.46M

Ranking

n/a

PE Ratio

32.30

Stock Price

€16.90

Market Cap Chart

Since May 16, 2014, Theravance Biopharma's market cap has increased from 16.00 to 807.81M, an increase of 5,048,810,269.08%. That is a compound annual growth rate of 354.35%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	807.81M	0.04%
Dec 31, 2025	807.48M	80.66%
Dec 31, 2024	446.95M	-11.74%
Dec 29, 2023	506.39M	-28.28%
Dec 30, 2022	706.03M	-1.40%
Dec 31, 2021	716.07M	-22.96%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
tonies SE	1.18B
Sedlmayr Grund und Immobilien AG	983.95M
Berliner Effektengesellschaft AG	886.48M
Northern Data AG	815.94M
Maschinenfabrik Berthold Hermle AG	787.50M
Paul Hartmann AG	777.83M
EUROKAI GmbH & Co. KGaA	701.68M
FRoSTA Aktiengesellschaft	656.73M

Market Cap Rankings